Brad Sorenson, Providence Therapeutics

from Afternoons with Rob Breakenridge · host CHQR / Curiouscast

We spoke with Providence Therapeutics CEO Brad Sorenson about the development of their coronavirus vaccine and the significance of the 2-million dose order placed by Manitoba Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Feb 13, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Brad Sorenson, Providence Therapeutics

0:00 20:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Afternoons with Rob Breakenridge?

This episode is 20 minutes long.

When was this Afternoons with Rob Breakenridge episode published?

This episode was published on February 13, 2021.

Can I download this Afternoons with Rob Breakenridge episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!